Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00910507 · ClinicalTrials.gov registry record · NA

The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial

A NA study of Diabetes Mellitus, Type 2, sponsored by University of Central Arkansas.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT00910507: Completed NA study of Diabetes Mellitus, Type 2, sponsored by University of Central Arkansas.

NCT00910507 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by University of Central Arkansas. The registered enrollment target is 24 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00910507, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by University of Central Arkansas.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized clinical trial is to investigate the impact of physical therapist-directed exercise counseling combined with fitness center-based exercise training on stage of exercise behavior in people with type 2 diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise counseling
  • BEHAVIORAL Supervised exercise training

Study Locations (1)

Arkansas

  • University of Central Arkansas - Conway

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2007-09
Est. Completion 2008-07
Phase NA
University of Central Arkansas

3 total trials

What the finished NCT00910507 record still lists

NCT00910507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Exercise counseling is the first listed.

NCT00910507 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT00910507 about?

NCT00910507 is a clinical study titled "The Impact of Exercise Counseling on Exercise Behavior in People With Type 2 Diabetes: A Randomized Clinical Trial". The purpose of this randomized clinical trial is to investigate the impact of physical therapist-directed exercise counseling combined with fitness center-based exercise training on stage of exercise behavior in people with type 2 diabetes.

What is the current status of trial NCT00910507?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-09. Estimated completion is 2008-07.

What conditions does trial NCT00910507 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00910507?

The interventions under investigation include: Exercise counseling (BEHAVIORAL), Supervised exercise training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00910507?

This trial is sponsored by University of Central Arkansas, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00910507 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00910507's enrollment target sits among peer trials

24 311th of 348 higher than 28 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00910507, the US trial registry maintained by the National Library of Medicine. NCT00910507 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.